Laboratory of Pharmaceutical Process Analytical Technology, Department of Pharmaceutical Analysis, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium.
Johnson & Johnson Global Technical Operations, Pharmaceutical Mfg (PM) Platform, Division of Janssen Pharmaceutica, Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium.
Eur J Pharm Sci. 2019 Apr 30;132:106-117. doi: 10.1016/j.ejps.2019.02.036. Epub 2019 Mar 1.
Recently, an innovative continuous manufacturing technology for a pharmaceutical oral suspension was proposed, based on two consecutive mixing units. A limitation of this technology is the need to dissolve or disperse powder-based raw materials in a liquid via a batch step before continuous manufacturing. Therefore, the aim of the current study was to develop and investigate a method to introduce powders continuously into the existing equipment via the implementation of two upstream continuous unit operations: a powder feeder and powder dispersing unit. A pharmaceutical cream was selected as model formulation to demonstrate the flexibility of the continuous manufacturing technology towards different types of semi-solid and liquid formulations. The ability to continuously feed and disperse active pharmaceutical ingredient (API) using the proposed method was assessed via an experimental design, in which the impact of several process parameters of the powder dispersing unit on the API concentration (relative error (RE) and relative standard deviation (RSD)) was examined. A Raman spectroscopic method was developed to quantify the API concentration in-line after the powder dispersing step. The API concentration was independent of the process parameters and fell within the acceptance limits, except for two experimental runs where a deviating API concentration was observed. These results demonstrate that the continuous powder feeding and dispersing method was suitable, and that a completely continuous manufacturing system was obtained. To achieve raw material traceability and understanding the mixing behavior, the residence time distribution (RTD) of a tracer inside the continuous manufacturing equipment was determined using a colorimetric technique. The time required to remove all tracer from the powder dispersing unit operation was very long (1481 s) and therefore the volume inside this unit operation should be reduced by designing new equipment with smaller dimensions. At the two consecutive mixing units, the peak and mean residence time were influenced by throughput, whereas mixing speed in both mixing units had a significant impact on the degree of axial mixing. Finally, the continuously manufactured cream had a similar rheological behavior as the original batch-wise manufactured cream.
最近,提出了一种基于两个连续混合单元的制药口服混悬液连续制造技术。该技术的一个局限性是需要在连续制造之前通过分批步骤将基于粉末的原料溶解或分散在液体中。因此,本研究的目的是开发并研究一种通过实施两个上游连续单元操作(粉末给料器和粉末分散单元)将粉末连续引入现有设备的方法。选择一种制药乳膏作为模型制剂,以证明连续制造技术对不同类型的半固态和液态制剂的灵活性。通过实验设计评估了使用所提出的方法连续进料和分散活性药物成分 (API) 的能力,其中考察了粉末分散单元的几个工艺参数对 API 浓度(相对误差 (RE) 和相对标准偏差 (RSD)) 的影响。开发了一种拉曼光谱法在粉末分散步骤后在线定量 API 浓度。API 浓度与工艺参数无关,且在可接受范围内,除了两个实验运行中观察到 API 浓度偏离。这些结果表明,连续粉末进料和分散方法是合适的,并且获得了完全连续的制造系统。为了实现原材料可追溯性并了解混合行为,使用比色技术确定示踪剂在连续制造设备中的停留时间分布 (RTD)。从粉末分散单元操作中去除所有示踪剂所需的时间非常长(1481 s),因此应通过设计具有较小尺寸的新设备来减小该单元操作的体积。在两个连续混合单元中,峰和平均停留时间受到通过量的影响,而在两个混合单元中的混合速度对轴向混合程度有显著影响。最后,连续制造的乳膏具有与原始批处理制造乳膏相似的流变行为。